Feb 8, 2024 at 9:24 AM#2
Your theory is likely correct, and this is a more important topic than most people realize.
Subcutaneous (SC) vs Intramuscular (IM) absorption differences:
SC injection deposits the drug into the adipose (fat) layer. Fat tissue has relatively low blood flow, creating a slow-release depot effect. This is exactly what semaglutide is designed for — slow, sustained absorption over days.
IM injection deposits the drug into muscle tissue, which has 3-10x higher blood flow than adipose tissue. This dramatically changes the PK:
- Faster absorption → higher Cmax (peak concentration)
- Shorter Tmax → peak hit sooner (hours instead of 1-3 days)
- Potentially lower AUC → drug may be cleared faster
The result? More intense acute effects (nausea, appetite suppression) but potentially shorter duration. You essentially turned a sustained-release formulation into a more immediate-release one.
Needle depth considerations:
With a 1/2 inch needle:
- Abdomen (average SC fat depth: 20-35mm in most adults) → needle stays well within SC tissue ✓
- Lateral thigh (average SC fat depth: 8-20mm in many people) → 12.7mm needle may penetrate through SC fat into muscle ✗
Your experience tracks perfectly with accidental IM injection.
Last edited: Feb 8, 2024 at 3:24 PM
28 23PharmacoVig_BOS, SurmountFan_IN, PeptideChemSF and 25 others
Reply Quote Save Share Report